| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | +15.7% |
| Cost of Revenue | $4.9M | +24.7% |
| Gross Profit | $6.3M | +9.6% |
| R&D Expense | $534K | +96.4% |
| SG&A Expense | $3.6M | +3.2% |
| Operating Income | -$1.2M | -76.7% |
| Interest Expense | $614K | -22.4% |
| Income Tax | $0 | — |
| Net Income | $303K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | +400.3% |
| Accounts Receivable | $1.6M | +87.1% |
| Inventory | $745K | -19.5% |
| Current Assets | $5.7M | +76.2% |
| Total Assets | $16.2M | -0.5% |
| Current Liabilities | $3.5M | -28.8% |
| Long-term Debt | $1.7M | -14.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | -825.0% |
| Capital Expenditures | $120K | -41.6% |
| Investing Cash Flow | $3.9M | +1988.3% |
| Financing Cash Flow | -$472K | -499.7% |
| Free Cash Flow | -$1.6M | -340.3% |
| +133.6% |
| Total Liabilities |
| $11.9M |
| -12.5% |
| Stockholders' Equity | $4.3M | +59.0% |